Annovis is a clinical stage, drug platform company addressing neurodegeneration, such as Alzheimer's disease in Down syndrome (AD-DS), Alzheimer's disease (AD) and Parkinson's disease (PD). By the end of 2024, Annovis expect to have conducted two pivotal studies for ANVS-401, one in AD-DS and one in PD, and to have filed a new drug application (NDA) with the U.S. Food and Drug Administration (FDA). Annovis principal executive offices are located at 1055 Westlakes Drive, Suite #300, Berwyn, PA 19312

Annovis Bio Inc

Should you buy, sell, or hold Annovis Bio Inc (ANVS) ?

Annovis Bio Inc (ANVS) : Buy or Sell